Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Bicara Therapeutics Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
BCAX
Nasdaq
2834
www.bicara.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Bicara Therapeutics Inc.
Bicara Therapeutics (BCAX) Stock Gets Fair Value Trim As Analysts Split On Ficera
- Nov 12th, 2026 6:13 pm
Bicara Therapeutics Inc (BCAX) Q3 2026 Earnings Call Highlights: Strong Enrollment Momentum and ...
- Nov 10th, 2026 4:02 am
Bicara (BCAX) Q3 2026 Earnings Call Transcript
- Nov 9th, 2026 12:43 pm
Bicara Therapeutics Inc. Common Stock Q3 2026 Earnings Call Summary
- Nov 9th, 2026 10:55 am
What Bicara Therapeutics (BCAX) Said on Its Q3 Earnings Call
- Nov 9th, 2026 9:15 am
Bicara Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
- Nov 9th, 2026 5:30 am
Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- Nov 4th, 2026 6:30 am
Bicara Therapeutics to Report Third Quarter 2026 Financial Results and Business Updates on November 9, 2026, at 8:30 AM ET
- Nov 2nd, 2026 6:30 am
Bicara Therapeutics (BCAX) Stock May Look Overvalued On Book Value
- Oct 10th, 2026 4:09 am
Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- Oct 5th, 2026 6:30 am
Can Bicara (BCAX) Commercialize Ficera? Breakthrough 3-Year Data Faces Execution Risk in C-Suite Overhaul
- Aug 19th, 2026 7:56 am
Bicara Therapeutics (BCAX) Q2 2026 Earnings Call Transcript
- Aug 18th, 2026 9:13 am
Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
- Aug 14th, 2026 6:30 am
Leadership Shake-Up And Ficerafusp Alfa Milestone Timeline Might Change The Case For Investing In Bicara Therapeutics (BCAX)
- Aug 13th, 2026 4:10 am
Bicara Therapeutics' Cancer Study On Track for 2026 Enrollment, Wedbush Says
- Aug 11th, 2026 11:28 am
Bicara Therapeutics Inc. Common Stock Q2 2026 Earnings Call Summary
- Aug 11th, 2026 11:15 am
Bicara Therapeutics stock gains 3% as pivotal trial enrollment advances
- Aug 11th, 2026 8:17 am
Bicara Therapeutics Q2 Earnings Call Highlights
- Aug 11th, 2026 8:04 am
Scroll